Skip to content

DR. JOHAN VAN STAPPEN

Active
Private limited companyfounded 20188 yrs activeFerdinand Coosemansstraat 96, 2600 Antwerpen, BelgiumKBO/BCE: BE 0704.806.453

DR. JOHAN VAN STAPPEN has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €234k and a net result of €215k. The figures fluctuate too strongly year-on-year for a reliable trend projection. The computed 12-month bankruptcy probability is 1.0% (low).

Checked score

Score 2025
80 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18k at 30 days acceptable
Liquidity ample (current ratio 9.15 against 4.07 in 2024; short-term debt: 10.5% and cash: 11.6% of total assets), and 10.5% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
89.5%
Return on assets
82.4%
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 8 years 0 10 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
29 d early
2024
1 d early
2023
2 d late
2022
28 d early
2021
34 d early
2020
5 d early
2019
2 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€234k▼ 42.7%
2024 · €408k
2018: €157k 2019: €268k 2020: €448k 2021: €20k 2022: €61k 2023: €273k 2024: €408k
2018 → 2025
Total assets
€261k▼ 51.4%
2024 · €537k
2018: €209k 2019: €273k 2020: €448k 2021: €641k 2022: €289k 2023: €293k 2024: €537k
2018 → 2025
Net result
€215k▼ 8.3%
2024 · €235k
2018: €145k 2019: €105k 2020: €180k 2021: €179k 2022: €200k 2023: €212k 2024: €235k
2018 → 2025
Working capital
€223k▼ 44.1%
2024 · €398k
2018: €157k 2019: €267k 2020: €445k 2021: €15k 2022: €56k 2023: €270k 2024: €398k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€20k-€61k▲ 198%€273k▲ 348%€408k▲ 49.3%€234k▼ 42.7%
Operating result€230k-€263k▲ 14.4%€287k▲ 9.1%€311k▲ 8.2%€288k▼ 7.4%
Net result€179k-€200k▲ 11.7%€212k▲ 5.9%€235k▲ 10.5%€215k▼ 8.3%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200k€300kOperating result 2021: €230k€230kNet result 2021: €179k€179kOperating result 2022: €263k€263kNet result 2022: €200k€200kOperating result 2023: €287k€287kNet result 2023: €212k€212kOperating result 2024: €311k€311kNet result 2024: €235k€235kOperating result 2025: €288k€288kNet result 2025: €215k€215k20212022202320242025
The operating result falls in 2025; 2025 is 7% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €261k
Fixed assets €11k▲ 15.0%
Current assets €250k▼ 52.6%
Equity and liabilities €261k
Equity €234k▼ 42.7%
Debt €27k▼ 78.9%
The debt ratio falls from 24.1% to 10.5%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€292k
2024 · €314k
Cash flow
€219k
2024 · €237k
Solvency
89.5%
2024 · 75.9%
Current ratio
9.15
2024 · 4.07
Quick ratio
9.15
2024 · 4.07
Debt / equity
0.12
2024 · 0.32
ROE
92.0%
2024 · 57.5%
ROA
82.4%
2024 · 43.7%
Interest coverage
107.91
2024 · 117.84
Debt
€27k
2024 · €129k
Debt ≤ 1 year
€27k
2024 · €129k
Income taxes
€75k
2024 · €74k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€537k€261k
Fixed assets21/28€10k€11k
Tangible fixed assets22/27€10k€11k
Land and buildings22€803€188
Furniture and vehicles24€9k€11k
Current assets29/58€527k€250k
Amounts receivable within one year40/41€88k€80k
Trade receivables40€88k€80k
Current investments50/53€84k€131k
Cash at bank and in hand54/58€348k€30k
Deferred charges and accrued income490/1€7k€9k
Equity and liabilities
Total equity and liabilities10/49€537k€261k
Equity10/15€408k€234k
Contributions10/11€19k€19k=
Reserves13€389k€215k
Distributable reserves133€389k€215k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€129k€27k
Amounts payable within one year42/48€129k€27k
Trade debts44€0€4k
Suppliers440/4€0€4k
Taxes, remuneration and social security45€26k€17k
Taxes450/3€26k€17k
Other amounts payable47/48€103k€6k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€4k
Other operating charges640/8€666€807
Gross operating margin9900€314k€292k
Operating profit (loss)9901€311k€288k
Financial income75/76B€0€5k
Recurring financial income75€0€5k
Financial charges65/66B€3k€3k
Recurring financial charges65€3k€3k
Profit (loss) for the period before taxes9903€308k€290k
Income taxes67/77€74k€75k
Profit (loss) for the period9904€235k€215k
Profit (loss) for the period to be appropriated9905€235k€215k
Appropriation of the result
Profit (loss) to be appropriated9906€235k€215k
Transfer from equity791/2-€389k
Transfer to equity691/2€135k€215k
To other reserves6921€135k€215k
Profit to be distributed694/7€100k€389k
Return on contributions (dividend)694€100k€389k

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
02-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Liquidity doublescurrent ratio 9.15
Current ratio from 4.07 to 9.15; short-term debt falls from €129k to €27k.
30-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2018net €235k ▲10.5%
Operating result €311k, net result €235k, both a record.
02-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 2 days late
2023
31-12
Financial Liquidity times 12current ratio 14.72
Current ratio from 1.25 to 14.72; short-term debt falls from €229k to €20k.
31-12
Financial Equity above €200kEq €273k ▲348%
6 profitable years in a row build equity to €273k.
03-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
27-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
26-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Liquidity times 15current ratio 747.09
Current ratio from 51.13 to 747.09; short-term debt falls from €5k to €596.
29-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Weakest financial yearnet €105k ▼27.8%
Net result drops to €105k, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity times 13current ratio 51.13
Current ratio from 3.99 to 51.13; short-term debt falls from €52k to €5k.
31-12
Financial Equity above €200kEq €268k ▲70.5%
2 profitable years in a row build equity to €268k.
22-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 22 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Ferdinand Coosemansstraat 962600 Antwerpen
Ground area
145 m²
Building footprint
90 m²
Volume, LiDAR
808 m³
Parcel 11003B0016/00C006, Flanders · tallest building 14.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
DR. JOHAN VAN STAPPEN
Ferdinand Coosemansstraat 96, 2600 AntwerpenSpecialist medical practice
since 20182.279.985.493
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11003B0016/00C006 Flanders 145 m² 1 · 90 m² 14.5 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded20-09-2018
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers

Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.